BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
Deloitte
Chubb
Daiichi Sankyo
AstraZeneca
Fish and Richardson
QuintilesIMS
Boehringer Ingelheim
Cantor Fitzgerald

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019950

« Back to Dashboard

NDA 019950 describes DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is fluconazole. There are twenty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the fluconazole profile page.
Summary for 019950
Tradename:DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:Pfizer
Ingredient:fluconazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength200MG/100ML (2MG/ML)
Approval Date:Jan 29, 1990TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength200MG/100ML (2MG/ML)
Approval Date:Jan 29, 1990TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength200MG/100ML (2MG/ML)
Approval Date:Sep 29, 1992TE:RLD:Yes

Expired US Patents for NDA 019950

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer DIFLUCAN IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 019950-001 Jan 29, 1990 ➤ Subscribe ➤ Subscribe
Pfizer DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER fluconazole INJECTABLE;INJECTION 019950-004 Jan 29, 1990 ➤ Subscribe ➤ Subscribe
Pfizer DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER fluconazole INJECTABLE;INJECTION 019950-005 Jul 8, 1994 ➤ Subscribe ➤ Subscribe
Pfizer DIFLUCAN IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 019950-001 Jan 29, 1990 ➤ Subscribe ➤ Subscribe
Pfizer DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER fluconazole INJECTABLE;INJECTION 019950-002 Jan 29, 1990 ➤ Subscribe ➤ Subscribe
Pfizer DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER fluconazole INJECTABLE;INJECTION 019950-003 Sep 29, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Accenture
Julphar
Chinese Patent Office
Covington
Cipla
Merck
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot